Organon to Acquire Forendo Pharma

Organon (NYSE: OGN), and Forendo Pharma today announced that the companies have entered into a definitive agreement, under which Organon will acquire

Women's Health

You’ll Save On Water And Toilet Paper With These Bidet Attachments

Your butt’s in for a treat.

Read More
Women's Health

Howell Foundation diversifies and expands for broader impact on women’s health research

Spotlight: Operating under the phrase “Grow and prosper,” the Doris A.

Read More
Women's Health

Irving-based Biote CEO advocating for more women’s health research

Irving-based Biote is a hormone optimization company that offers patients personalized hormone therapy and clinical-grade nutraceuticals.

Read More